Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
87.61
+2.01 (2.35%)
Jun 1, 2026, 1:08 PM EDT - Market open
Abbott Laboratories Stock Forecast
Stock Price Forecast
According to 27 analysts polled by S&P Global, Abbott Laboratories stock has a consensus rating of "Buy" and an average price target of $117.29. The average 1-year stock price forecast is 33.88% higher than the current stock price, while the lowest is $92 (+5.01%) and the highest is $135 (+54.09%).
Price Target: $117.29 (+33.88%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Abbott Laboratories stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 15 | 15 | 16 | 16 | 16 | 16 |
| Buy | 6 | 6 | 6 | 6 | 5 | 4 |
| Hold | 7 | 7 | 7 | 7 | 7 | 7 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 28 | 28 | 29 | 29 | 28 | 27 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $115 | Buy | Maintains | $115 | +31.26% | May 29, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $109 | Buy | Maintains | $109 | +24.42% | May 19, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $115 | Buy | Maintains | $115 | +31.26% | Apr 29, 2026 |
| Citi | Citi | Buy Reiterates $102 → $108 | Buy | Reiterates | $102 → $108 | +23.27% | Apr 27, 2026 |
| Daiwa | Daiwa | Hold Downgrades $113 → $92 | Hold | Downgrades | $113 → $92 | +5.01% | Apr 22, 2026 |
Financial Forecast
Revenue This Year
50.29B
from 44.33B
Increased by 13.45%
Revenue Next Year
54.80B
from 50.29B
Increased by 8.97%
EPS This Year
3.98
from 3.72
Increased by 6.89%
EPS Next Year
4.64
from 3.98
Increased by 16.71%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 50.6B | ||
| Avg | 50.3B | ||
| Low | 47.8B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 14.1% | ||
| Avg | 13.5% | ||
| Low | 7.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 4.69 | ||
| Avg | 3.98 | ||
| Low | 3.01 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 26.0% | ||
| Avg | 6.9% | ||
| Low | -19.1% |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Financial forecast data provided by S&P Global Market Intelligence. The data is sourced from Wall Street analysts. Data sources.